Magda Ali
Canny CLO managers have diversified into other credit instruments so as to avoid becoming a hostage to unfavourable market conditions, whilst a brave few are starting to raise new vehicles. But that still leaves a big hole in European liquidity once the previous generation of funds reach the end of their reinvestment periods. Magda Ali reports.
.jpg "ICG nears €400m CLO close")
The London-listed asset manager hopes to conclude fundraising for its latest CLO by the end of June.
.JPG "Hercules Tech backs biopharmaceutical with $30m")
 The biotechnology finance firm has provided a three-tranche $45m term loan to drug developer Anacor Pharmaceuticals.   Â
The frontier Asia and Sub-Saharan Africa specialist private equity firm has provided a term loan to Zimbabwean bank NMB Bank.
.jpg "LPs boost allocation to private debt")
A third of LPs surveyed in Coller Capital’s latest ‘barometer’ plan to increase their allocations to credit investments, whilst half already have or plan to have exposure to private debt funds.  Â
Avebury Capital has steadily expanded its private placement and advisory debt unit in the past year; securing contracts with likes of ICG and Prefequity. James Newsome, managing partner at the firm shares some lessons learnt on the road. Â
.jpg "S&P warns of $3.9trn European refinancing challenge")
The rating agency raised concerns about the ability of European lenders to meet corporate funding needs as they deal with the impact of sluggish economic growth. Â
.jpg "Saas Capital backs Monet Software")
The software-specialist debt fund manager has made its fifth allocation from its first debt fund.
The Chicago-based debt fund manager has closed its third transaction with a portfolio company of Freeman Spogli.
/June/News/insulin80.jpg "Capital Royalty backs Valeritas with $100m")
The healthcare-focused debt fund manager has provider a term loan to insulin device manufacturer Valeritas.